Fed Holds Rates Steady, Punts on Middle East Risk Outlook
The Federal Reserve keeps policy unchanged as global tensions weigh on growth and inflation prospects. The move delay...
Which Is Better Retirement Funds Index Or Target Date
This piece analyzes whether retirement funds should favor index or target date options, emphasizing long-term planning and goal alignment.
26,209 articles
The Largest Infrastructure Buildout: Real Estate Opportunity
A sweeping wave of public and private spending is reshaping where people live and work. This is the largest infrastru...
Schwab (Schw) 2025 Earnings: What Investors Should Know
As Schwab prepares to report Q4 2025 results, investors want clarity on what drives earnings and where risks lie. Thi...
Bitcoin Down From All-Time High: What History Says Next
Bitcoin has retraced from its peak, triggering nerves for many investors. This article uses historical cycles to expl...
Celsius Founder Alex Mashinsky Seeks 12-Year Sentence Vacate
Celsius founder Alex Mashinsky has filed to vacate a 12-year crypto fraud sentence, signaling a dramatic turn in a ca...
Tempus AI Posts Revenue Growth, Misses Profit Target
Tempus AI reported an 83% jump in Q4 revenue to $367 million but failed to hit positive full-year profitability, guid...
Best Space Before Summer: Top Space ETFs for a Rally
As markets enter the quieter summer season, space-themed investing offers a targeted way to capture innovation. This ...
Stock Market Today, Feb.: Crypto Infrastructure Stocks Jump
A notable rally in crypto infrastructure stocks is shaping sentiment for the broader market. This article breaks down...
Here Wednesday’s Wall Street Analyst Calls Stir Markets
Wednesday brought a wave of fresh analyst calls spanning tech, industrials, and defense as traders weigh earnings and...
Wells Fargo Raises Targets on UNFI as MTDR Gains Follow
Analysts boosted targets on UNFI and MTDR after solid quarterly results, signaling renewed investor optimism as pipel...
Wall Street Cuts Mosaic Again: UBS Slashes Target to $27
UBS cuts Mosaic’s price target to $27, citing squeezed phosphate margins from higher sulfur and input costs, as Wall ...
Phathom Pharma Upgraded by Barclays to Overweight $18 Target
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status